PODCAST: VR, Biofeedback, and Digital Therapeutics: The Future of Mental Health

The following podcast was originally published by Psychedelics Today on their Youtube Page. Psychedelics Today is the planetary leader in psychedelic media, storytelling, and education.You can see the original publishing here.

In this episode of the podcast, Joe Moore interviews Lyle Maxson: Co-Founder and Chief Strategy Officer of Entheo Digital, a “technodelic” company focusing on digital therapeutics and virtual reality as adjuncts to psychedelic-assisted therapy, and theoretically, as new forms of medicine.

Maxson discusses using VR before and after psychedelic experiences as a priming and integration tool; VR's potential to ease first-time trip anxiety; Entheo Digital's SoundSelf system and the powerful influence of biofeedback; and the question of whether or not technology (on its own) could initiate a non-ordinary state of consciousness with the same benefits as one brought on by psychedelics. He also talks about the likelihood of using different tools to be able to naturally activate endogenous DMT; the idea of a Steam-like internet marketplace for digital medicine; the possibility for technology to trigger lucid dreaming; the concept of highly-personalized digital schooling, and the tough question of how to not become so reliant on technology in such a quickly advancing technological world. And how can we not use technology for escapism, and instead for good?


Have Questions?


Lyle Maxson

Chief Strategic Officer

• Co-founder at Andromeda Entertainment

• Strategic partnerships & publishing in XR

• Music industry executive specialized in Mixed Reality productions

Previous
Previous

PODCAST: Virtual Reality and the Future of Psychedelics

Next
Next

What Psychedelic Tech Works Best with a Float Tank?